Article Text

Download PDFPDF

Combined arteriovenous sheathotomy and intraoperative intravitreal triamcinolone acetonide for branch retinal vein occlusion
Free
  1. John C Hwang,
  2. Susan K Gelman,
  3. Howard F Fine,
  4. Stanley Chang,
  5. Lucian V Del Priore
  1. Edward S Harkness Eye Institute, Columbia University Medical Center, New York, New York, USA
  1. Correspondence to Dr Stanley Chang, Edward S Harkness Eye Institute, Columbia University Medical Center, 635 West 165th Street, New York, NY 10032, USA; sc433{at}columbia.edu

Abstract

Purpose To describe the treatment of macular oedema secondary to branch retinal vein occlusion (BRVO) with concomitant pars plana vitrectomy/arteriovenous sheathotomy and intraoperative intravitreal triamcinolone acetonide.

Methods Retrospective case series.

Results Four eyes of four patients were identified. Patients improved from a mean best-corrected visual acuity of 20/124 at baseline to 20/122 at month 1, 20/83 at month 3, 20/74 at month 6, 20/59 at month 9 and 20/44 at month 12 (p=0.01). All patients demonstrated improvement in visual acuity and macular oedema on fluorescein angiography and/or optical coherence tomography (OCT).

Conclusion For patients with persistent macular oedema due to BRVO refractory to pharmacotherapy and/or laser photocoagulation, concomitant pars plana vitrectomy with arteriovenous sheathotomy and intravitreal triamcinolone may improve best-corrected acuity and reduce macular oedema on fluorescein angiography and OCT.

  • Retina
  • sheathotomy
  • triamcinolone acetonide
  • treatment surgery
  • vein occlusion

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Funding This study was supported by unrestricted funds from Research to Prevent Blindness, 645 Madison Avenue, Floor 21, New York, NY 10022-1010, USA.

  • Competing interests None declared.

  • Ethics approval This study was conducted with the approval of the New York Presbyterian Hospital Institutional Review Board.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Linked Articles

  • At a glance
    Harminder S Dua Arun D Singh